Telenet Turns to Benu Networks to Deliver Cloud-based Managed Business Services to the SOHO/SME Markets
Benu Networks, a leading provider of innovative virtual network solutions that enable service providers to rapidly create and deliver next generation IP services, today announced that Telenet, the largest provider of cable broadband services in Belgium, has selected their Virtual Service Edge (VSE) platform to enable the rapid delivery of tailored, managed service offerings for the small office/home office (SOHO) and small-to-medium enterprise (SME) markets. Telenet’s managed offerings address key business priorities such as guest connectivity, device level visibility, and security by supplying SOHO/SME customers with convenient IT support and cybersecurity at highly affordable rates.
Telenet recognized that SOHO/SME customers, which account for 99.8% of Belgium enterprises as reported by Eurostat, wanted a service customized to their business routine and activities. With Telenet’s new Wi-Fi Business offering, SOHOs/SMEs can easily set up multiple networks that are public for patrons and private for employees. A customized, template-driven, user portal empowers the small business manager to enhance engagement with patrons in multiple areas, including Facebook check in, loyalty programs, and targeted promotions by using the analytical data collected. It enables better network monitoring of bandwidth, time usage, and allows for “time of day” restrictions. In addition, the service is in line with the new privacy guidelines that will come into effect in May 2018. Telenet’s new Wi-Fi Business service will be sold through the Telenet Business department which serves the business market in Belgium and Luxembourg.
“After an exhaustive selection process, Telenet is pleased to have chosen Benu Networks’ highly flexible architecture to deliver our new Wi-Fi Business service,” stated Stijn Vander Plaetse, Vice President, Product & Marketing, Telenet Business. “By moving key network functions to the cloud, this ingenious solution enables us to add new services rapidly and efficiently - seamlessly on top of our existing infrastructure. With the most compelling return on investment analysis, Benu Networks’ solution future proofed our network by delivering a single platform that supports the effortless launch of additional services going forward.”
Telenet utilizes Benu Networks’ Virtual Service Edge (VSE) platform, which leverages existing customer premises equipment (CPE)/IT infrastructure, to provide the new managed service. The VSE is a virtual software solution running on VMware network functions virtualization infrastructure (NFVI), and supports multiple services simultaneously. The VSE virtualizes complex CPE network functions, thereby transforming the service provider’s edge into a next generation, service delivery network to enable per device policy enforcement, visibility, and service stitching. This solution empowers Telenet to win within a highly competitive market with the service agility on par with over-the-top (OTT) providers, but with greater customer satisfaction and quality of experience (QoE) controls.
“We are pleased that VMware NFVi was chosen as the virtualization platform of choice by Benu Networks and Telenet,” said Honore LaBourdette, Vice President, Global Market Development, VMware. “Both companies have adopted VMware NFVi to enable digital transformation, and can benefit from a cost-effective deployment of next-generation services.”
“Benu Networks is thrilled to partner with Telenet Business to provide them the opportunity to address a critical market need with these vital business services for the SOHO/SME market,” said Mads Lillelund, CEO, Benu Networks. “Our Virtual Service Edge solution provides Telenet with the ability to rapidly address future market needs by launching additional revenue generating services from the platform - a critical requirement to successfully compete in today’s high-growth, IT cloud services marketplace.”
About Benu Networks: Benu Networks’ carrier-class Virtual Service Edge (VSE) software platform enables the rapid creation and delivery of next generation IP services over a converged infrastructure, and empowers service providers to increase revenue, expand market leadership, and meet the dynamic needs of their business, residential and mobile customers. For more information, please visit the Benu Networks website: www.benunetworks.com Follow us on Twitter @benunets.
VMware is a registered trademark of VMware, Inc. in the United States and other jurisdictions. All other marks and names mentioned herein may be trademarks of their respective companies.
Kelly Friedland, +1 781-640-4864
Director of Marketing
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aroma Bit to Develop Smartphone Embeddable Ultra-compact Silicon CMOS Based Smell Sensor That Has Dog Nose Equivalent Resolution in 1mm Squared Die Size23.7.2019 04:30:00 EEST | Press release
Aroma Bit launched a new subsidiary to develop the next generation smell sensor based on silicon CMOS sensor substrate that are ultra-compact, high resolution and low cost. The technology is realized by applying Aroma Bit developed smell sensor receptor membrane technology to ultra-sensitive silicon CMOS based ion imaging sensor technology developed by professor Kazuaki Sawada at Toyohashi University of Technology and associated companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005004/en/ Picture of 1mm squared die of silicon CMOS based smell sensor, with dog nose equivalent ~1,200 sensor pixels (Photo: Business Wire) Aroma Bit: http://www.aromabit.com Realizing smartphone embeddable smell sensor with dog nose equivalent ultra-high resolution smell sensor on only 1 millimeter square silicon die size Aroma Bit has developed and are currently selling a compact smell sensor that employs QCM or Quartz Crystal Micro
Logitech Delivers a Strong Start to Fiscal Year 2020 with Robust Sales and Profit Growth23.7.2019 04:00:00 EEST | Press release
Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the first quarter of Fiscal Year 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005781/en/ Logitech delivers a strong start to Fiscal Year 2020 with robust sales and profit growth. (Graphic: Business Wire) Q1 sales were $644 million, up 6 percent in US dollars and 9 percent in constant currency, compared to Q1 of the prior year. Q1 GAAP operating income grew 46 percent to $47 million, compared to $32 million in the same quarter a year ago. Q1 GAAP earnings per share (EPS) grew 17 percent to $0.27, compared to $0.23 in the same quarter a year ago. Q1 non-GAAP operating income grew 11 percent to $67 million, compared to $61 million in the same quarter a year ago. Q1 non-GAAP EPS grew 15 percent to $0.39, compared to $0.34 in the same quarter a year ago. Cash flow from operations was $37 million, compared to $12 million in the sa
Gilead Presents New Data on Biktarvy® for the Treatment of HIV in Women and in Virologically Suppressed Patients With Known Resistance22.7.2019 19:00:00 EEST | Press release
Gilead Sciences, Inc. (NASDAQ: GILD) today presented findings from two Phase 3 trials – a trial demonstrating the effectiveness of switching to Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg tablets, B/F/TAF) in women, and a trial evaluating the potential for the single tablet regimen to be an effective treatment option in virologically suppressed patients with known resistance to nucleo(s)tide or non-nucleo(s)tide reverse transcriptase inhibitors (NRTIs or NNRTIs). The use of Biktarvy in patients with known drug resistance is investigational. These data were presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) being held in Mexico City. “These data presented at IAS provide new information about the treatment of HIV among women and patients with known drug resistance,” said Diana Brainard, MD, Senior Vice President, HIV and Emerging Viruses, Gilead Sciences. “The studies further demonstrate the potential for Biktarvy to be an
IBC Celebrates Young Talent in the Industry22.7.2019 18:36:00 EEST | Press release
The media, entertainment and technology industry is changing. Attitudes are shifting, the next generation is consuming content differently to any before them and diverse and exciting content is being created to meet that demand in innovative formats. Driving this change is a new wave of industry talent, honoured at IBC with the first IBC Young Pioneer Award. Recognising the brightest, newest talent in the industry, this award will go to someone who has made a real impact with their passion, ambition and commitment and is making an outstanding contribution to our industry. “What we were looking for in the shortlist was, most importantly, real talent, a stand-out individual making a real difference in the industry,” said David Levine, VP, Programming - Kids, Europe & Africa/UK & Ireland, The Walt Disney Co. Ltd and Chair of the Judging Panel. “But we were also looking for a lasting legacy, for the Young Pioneer to be a leader today and a media guru of the future.” The call for entries so
Gilead Presents Proof-of-Concept Data for GS-6207, a First-in-Class Capsid Inhibitor, in People Living With HIV22.7.2019 18:00:00 EEST | Press release
Gilead Sciences, Inc. (NASDAQ: GILD) today presented the first clinical data in people living with HIV on GS-6207, an investigational, novel, selective, first-in-class inhibitor of HIV capsid function. The Phase 1b data demonstrate the first proof of concept that HIV capsid inhibition can lead to significant declines in viral load in vivo. In addition, Gilead presented preclinical data demonstrating that resistance to GS-6207 in vitro did not lead to resistance to other classes of drugs used in the treatment of HIV. These data were presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) in Mexico City. GS-6207 is an investigational long-acting antiretroviral agent that can be delivered subcutaneously. GS-6207 recently received breakthrough therapy designation from the U.S. Food and Drug Administration (FDA) as a potential therapy for heavily treatment-experienced people living with multi-drug resistant HIV. GS-6207 acts in a novel way compared with current
Pacific Drilling Appoints James W. Harris as Chief Financial Officer22.7.2019 16:42:00 EEST | Press release
Pacific Drilling S.A. (NYSE: PACD), one of the world’s leading deepwater drilling contractors, today announced that Pacific Drilling’s Board has appointed James W. Harris to serve as the Company’s Senior Vice President and Chief Financial Officer. Mr. Harris replaces Mr. Johannes (John) P. Boots, who, as previously announced, mutually agreed with the Company to step down from his position to pursue other opportunities. Mr. Harris has more than 30 years of experience in the energy industry in a variety of financial leadership, strategic and business planning roles. He most recently served as Executive Vice President, Drilling & Subsea for Forum Energy Technologies, Inc., having previously served Forum as Chief Financial Officer for 12 years. Bernie Wolford, the Company’s Chief Executive Officer, stated, “We sincerely appreciate the many contributions that John has made during his nearly 10-year tenure with Pacific Drilling and we wish him all the best in his future endeavors.” “We are e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom